Candy B, Jones L, Williams R, et al. Phosphodiesterase type 5 inhibitors in the management of erectile dysfunction secondary to treatments for prostate cancer: findings from a Cochrane systematic ...

A targeted focal therapy can now help prostate cancer patients as it promises same outcomes with fewer side effects than ...

Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...

New research from Edith Cowan University (ECU) has confirmed that erectile dysfunction in patients living with prostate cancer could be significantly improved through regular exercise. Sexual ...

A technique to improve the precision of prostate cancer surgery means that almost twice as many men preserve their erectile function compared to those undergoing standard surgery, according to results ...

Kenny Logan has opened up about his recovery, and the revival of his sex life, after undergoing treatment for prostate cancer. The former Scottish rugby union player was diagnosed with the condition ...

When you may think about men's urological health, prostate cancer is often the first condition that comes to mind. While ...

No significant association found between phosphodiesterase type 5 inhibitor use and biochemical recurrence after radical treatment. Oral drugs to treat erectile dysfunction after radical treatment for ...

New research from Edith Cowan University (ECU) has confirmed that erectile dysfunction in patients living with prostate cancer could be significantly improved through regular exercise. Sexual ...

The results of the NeuroSAFE PROOF trial, presented at the 2025 European Association of Urology (EAU) Congress in Madrid and published in TheLancet Oncology, raise the prospect of major quality of ...